FDA Determines Regulatory Review Period for TACK ENDOVASCULAR SYSTEM Patent Extension

Summary

The FDA has determined the regulatory review period for TACK ENDOVASCULAR SYSTEM, a medical device, and published the notice as required by law, following submissions to the USPTO for patent extension.